- Home
- BEAM vs DNUT Comparison
BEAM vs DNUT Comparison
Compare BEAM & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAM
- DNUT
- Stock Information
- Founded
- BEAM 2017
- DNUT 1937
- Country
- BEAM United States
- DNUT United States
- Employees
- BEAM N/A
- DNUT N/A
- Industry
- BEAM Biotechnology: Biological Products (No Diagnostic Substances)
- DNUT Food Chains
- Sector
- BEAM Health Care
- DNUT Consumer Staples
- Exchange
- BEAM Nasdaq
- DNUT Nasdaq
- Market Cap
- BEAM 2.0B
- DNUT 1.9B
- IPO Year
- BEAM 2020
- DNUT 2021
- Fundamental
- Price
- BEAM $24.35
- DNUT $11.47
- Analyst Decision
- BEAM Buy
- DNUT Buy
- Analyst Count
- BEAM 10
- DNUT 9
- Target Price
- BEAM $47.00
- DNUT $15.56
- AVG Volume (30 Days)
- BEAM 828.9K
- DNUT 1.3M
- Earning Date
- BEAM 11-06-2024
- DNUT 11-07-2024
- Dividend Yield
- BEAM N/A
- DNUT 1.22%
- EPS Growth
- BEAM N/A
- DNUT N/A
- EPS
- BEAM N/A
- DNUT N/A
- Revenue
- BEAM $352,567,000.00
- DNUT $1,739,779,000.00
- Revenue This Year
- BEAM N/A
- DNUT $2.13
- Revenue Next Year
- BEAM $8.94
- DNUT $7.84
- P/E Ratio
- BEAM N/A
- DNUT N/A
- Revenue Growth
- BEAM 339.83
- DNUT 8.06
- 52 Week Low
- BEAM $16.95
- DNUT $9.18
- 52 Week High
- BEAM $49.50
- DNUT $17.84
- Technical
- Relative Strength Index (RSI)
- BEAM 47.85
- DNUT 56.67
- Support Level
- BEAM $22.67
- DNUT $10.84
- Resistance Level
- BEAM $27.42
- DNUT $11.57
- Average True Range (ATR)
- BEAM 1.23
- DNUT 0.36
- MACD
- BEAM 0.26
- DNUT 0.07
- Stochastic Oscillator
- BEAM 37.92
- DNUT 92.31
About BEAM Beam Therapeutics Inc.
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.
About DNUT Krispy Kreme Inc.
Krispy Kreme Inc is a sweet treat brands company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in- your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing ecommerce and delivery business. The company conducts its business through the following three reported segments namely U.S., includes all operations in the U.S. and Canada, Insomnia Cookies shops, and the Branded Sweet Treat Line; International includes operations in the U.K., Ireland, Australia, New Zealand, and Mexico; and Market Development includes franchise operations across the globe, as well as operations in Japan. It derives maximum revenue from U.S. Segment.